New England Biolabs (NEB) is a globally recognized biotechnology company specializing in the discovery, development, and supply of innovative enzymes, reagents, and solutions for molecular biology research, diagnostics, and genomic applications. The company supports scientists and organizations advancing breakthroughs in life sciences, synthetic biology, and precision medicine.
Campaign Objective
New England Biolabs partnered with Group Futurista to host a targeted virtual leadership summit designed to:
- Engage senior life sciences, genomics, and research decision-makers
- Showcase innovations in molecular biology tools and workflows
- Generate enterprise-qualified demand opportunities
- Position NEB as a thought leader in advanced genomic and molecular research solutions
Target Audience Roles
- Chief Scientific Officers
- Genomics Directors
- Research Lab Heads
- Molecular Biologists
- Bioinformatics Leaders
- Biotech Innovation Executives
- Diagnostics Strategy Leaders
Event Metrics
| Metric | Result |
| Total Registrations | 342+ |
| Live Attendance | 43% (approx. 147 attendees) |
| On-Demand Views | 259+ within 30 days |
| Industries Represented | 26 sectors |
| Director Level & Above | 78% |
Event Delivery & Engagement
The summit featured:
- Strategic keynote on future-ready genomics research infrastructure
- Executive panel on next-generation molecular innovation
- Live demonstration of advanced enzyme technologies
- Interactive polls on research challenges and priorities
- Real-time Q&A and curated networking discussions
Engagement Highlights
- Strong turnout from biotech and research decision-makers
- 69 audience questions submitted live
- Average viewing duration: 44 minutes
- Peak engagement during genomics workflow demo
- High participation in scientific knowledge-sharing sessions
Lead Quality & Conversations Generated
Qualified Leads Delivered: 183 MQLs
Lead Profile
- Research institutions expanding genomic capabilities
- Biotech firms scaling molecular testing workflows
- Diagnostics companies enhancing assay precision
- Organizations adopting next-generation sequencing solutions
Key Conversation Themes
- Improving accuracy in molecular analysis
- Accelerating research timelines with optimized reagents
- Enhancing reproducibility in lab workflows
- Scaling genomics innovation programs
- Integrating automation into laboratory environments
Post-Event Interest Signals
Participants requested:
- Technical consultations
- Product demonstrations
- Workflow optimization sessions
- Pilot evaluation programs
Results Snapshot
| KPI | Outcome |
| Qualified Leads | 183 |
| Senior Decision Makers | 78% |
| Avg Engagement | 44 mins |
| Questions Asked | 69 |
| Follow-Up Requests | Strong |
| Pipeline Potential | High |
Outcome
Through this focused virtual leadership summit, New England Biolabs successfully:
- Engaged high-intent scientific and biotech leaders
- Strengthened positioning as a molecular biology innovation authority
- Generated strong enterprise pipeline opportunities
- Initiated strategic conversations with qualified prospects
- Achieved measurable ROI from a single campaign partnership
